The drink has long been known to cause serious health problems, and now experts have warned it can increase your risk of ...

AI-powered models can analyze large datasets in real-time, optimizing organ distribution across wider geographic regions.

Early research shows a one-time gene therapy has potential for addressing both the liver and lung disease that patients with ...

From the French senator going viral in the US to the hidden menace lurking in French soil, via French regional stereotypes ...

Discover preclinical studies that indicate that empagliflozin reduces liver fat, improves liver function markers, and ...

The scoring method, called the Tumor Immune Microenvironment Spatial System, or TIMES, is the first tool in the world to ...

Consuming too little salt in your daily diet could be as dangerous as eating too much. According to Harvard-educated Dr.

Medically reviewed by Jay N. Yepuri, MD FibroScan is the brand name for transient elastography, an abdominal ultrasound that ...

Korro Bio disclosed that the Food and Drug Administration granted orphan drug designation to its potential genetic disorder drug KRRO-110. Shares rose 17.6% to $29 in premarket trading. The stock is ...

All the latest breaking news on United States. Browse ibtimes archives of photos, videos and articles on United States.

KRRO-110 is the first RNA editing development candidate from Korro’s proprietary OPERA TM platform and is currently being evaluated in the Phase 1/2a REWRITE clinical study for AATD. Dosing of the ...

Korro Bio, Inc. (Korro) (Nasdaq: KRRO), a clinical-stage biopharmaceutical company focused on developing a new class of genetic medicines based on ...